Related Experiment Video
Updated: Jun 23, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
Chihiro Ohtsubo1, Daisuke Shiokawa, Masami Kodama
1Radiobiology Division, National Cancer Center Research Institute, Tokyo, Japan.
Abstract:
The mdm2 and mdmx oncogenes play essential yet nonredundant roles in synergistic inactivatiosn of p53. However, the biochemical mechanism by which Mdmx synergizes with Mdm2 to inhibit p53 function remains obscure. Here we demonstrate that, using nonphosphorylatable mutants of Mdmx, the cooperative inhibition of p53 by Mdmx and Mdm2 was associated with cytoplasmic localization of p53, and with an increase of the interaction of Mdmx to p53 and Mdm2 in the cytoplasm. In addition, the Mdmx mutant cooperates with Mdm2 to induce ubiquitination of p53 at C-terminal lysine residues, and the integrity of the C-terminal lysines was partly required for the cooperative inhibition. The expression of subcellular localization mutants of Mdmx revealed that subcellular localization of Mdmx dictated p53 localization, and that cytoplasmic Mdmx tethered p53 in the cytoplasm and efficiently inhibited p53 activity. RNAi-mediated inhibition of Mdmx or introduction of the nuclear localization mutant of Mdmx reduced cytoplasmic retention of p53 in neuroblastoma cells, in which cytoplasmic sequestration of p53 is involved in its inactivation. Our data indicate that cytoplasmic tethering of p53 mediated by Mdmx contributes to p53 inactivation in some types of cancer cells.
Insights
MDM2 and MDMX oncogenes synergistically inactivate p53. This study reveals MDMX sequesters p53 in the cytoplasm, enhancing its inactivation by MDM2, a key mechanism in some cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The MDM2 and MDMX oncogenes are crucial for the synergistic inactivation of the tumor suppressor p53.
- The precise mechanism by which MDMX enhances MDM2's inhibition of p53 remains unclear.
Purpose of the Study:
- To elucidate the biochemical mechanism of MDMX-MDM2 synergistic p53 inactivation.
- To investigate the role of subcellular localization of MDMX in p53 regulation.
Main Methods:
- Utilized nonphosphorylatable and subcellular localization mutants of MDMX.
- Employed RNA interference (RNAi) to inhibit MDMX expression.
- Assessed p53 localization, interaction with MDM2/MDMX, and ubiquitination in neuroblastoma cells.
Main Results:
- Cooperative inhibition of p53 by MDMX and MDM2 correlated with p53's cytoplasmic localization and increased MDMX-p53-MDM2 interactions in the cytoplasm.
- MDMX and MDM2 induced p53 ubiquitination at C-terminal lysine residues, partly dependent on lysine integrity.
- Cytoplasmic MDMX tethered p53, inhibiting its activity; nuclear localization mutants of MDMX reduced cytoplasmic p53 retention.
Conclusions:
- Cytoplasmic sequestration of p53 by MDMX is a significant contributor to p53 inactivation in certain cancer cells.
- MDMX's subcellular localization dictates p53 localization and activity, highlighting a novel mechanism of tumor suppression evasion.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Anaphase Promoting Complex
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Inhibition of Cdk Activity

